Active ingredientElbasvirCat. No. P-E018-001CAS 1370468-36-2Family · Pharmaceutical analytical standards
Elbasvir
An antiviral that blocks the NS5A protein of the hepatitis C virus, which the virus needs to replicate and assemble. Approved in the United States in January 2016, in a single tablet with grazoprevir, for chronic hepatitis C of genotypes 1 and 4. This family brings together the active ingredient and labelled standards.
Did you know?It was approved only paired with grazoprevir, which hits another viral target, the NS3/4A protease; on its own it had been tested for just five days in one of the first clinical studies.
Go to the active ingredient →Active ingredientElbasvirCat. No. P-E018-001CAS 1370468-36-2
Isotopically labelledElbasvir-d6Cat. No. P-E018-002CAS 2101183-01-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.